BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 1518267)

  • 1. Effectiveness of nationwide screening program for neuroblastoma in Japan.
    Hisashige A;
    Glob J Health Sci; 2014 Apr; 6(4):94-106. PubMed ID: 25001552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma.
    Humpl T
    World J Urol; 1995; 13(4):233-9. PubMed ID: 8528298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is neuroblastoma screening evaluation needed and feasible?
    Estève J; Parker L; Roy P; Herrmann F; Duffy S; Frappaz D; Lasset C; Hill C; Sancho-Garnier H; Michaelis J
    Br J Cancer; 1995 Jun; 71(6):1125-31. PubMed ID: 7779698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early neuroblastoma detection in Germany. On the status of the Hamburg-Stuttgart cooperative pilot study].
    Schilling FH; Erttmann R; Dohrmann S; Erb N; Winkler K; Gross U; Treuner J
    Klin Padiatr; 1992; 204(4):282-7. PubMed ID: 1518266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
    Tuchman M; Lemieux B; Auray-Blais C; Robison LL; Giguere R; McCann MT; Woods WG
    Pediatrics; 1990 Nov; 86(5):765-73. PubMed ID: 2152340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
    Scriver CR; Gregory D; Bernstein M; Clow CL; Weisdorf T; Dougherty GE; Auray-Blais C; Giguère R; Lemieux B; Laberge C
    CMAJ; 1987 May; 136(9):952-6. PubMed ID: 3105859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
    Berthold F; Baillot A; Hero B; Schurr P; Nerenz A; Hunneman DH; Sander J
    J Clin Oncol; 1999 Apr; 17(4):1200. PubMed ID: 10561179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for neuroblastoma in the northern region of England. Laboratory aspects.
    Seviour JA; McGill AC; Craft AW; Parker L; Bell S; Cole M; Smith J; Hawkins E; Brown J; Dale GA
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):332-6. PubMed ID: 1456399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The "Lower Saxony/Northern Rhine-Westphalia" Neuroblastoma Screening Project: on the need for epidemiologic comparison].
    Berthold F; Sander J; Baillot A; Hunneman DH; Michaelis J
    Klin Padiatr; 1992; 204(4):288-92. PubMed ID: 1518267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J
    J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
    Carlsen NL
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroblastoma in the Auvergne region from 1986 to 1991: epidemiological data].
    Gembara P; Dechelotte P; Chazal J; Chauvin F; Chopard P; Goddon R; Goumy P; Masson A; Malpuech G; Deméocq F
    Pediatrie; 1993; 48(11):801-4. PubMed ID: 8058441
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.